Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Cancer Cell|September 13, 2011
Rho kinase regulates the survival and transformation of cells bearing oncogenic forms of KIT, FLT3, and BCR-ABLRaghuveer Singh Mali, Baskar Ramdas, Peilin Ma, et al.
Plos One|August 21, 2012
Single nucleotide polymorphism array lesions, TET2, DNMT3A, ASXL1 and CBL mutations are present in systemic mastocytosisFabiola Traina, Valeria Visconte, Anna M Jankowska, et al.
Leukemia & Lymphoma|September 30, 2020
A multicenter comparative acute myeloid leukemia study: can we explain the differences in the outcomes in resource-constrained settings?Douglas R A Silveira, Juan L Coelho-Silva, Wellington F Silva, et al.
Blood Advances|May 27, 2020
Integrating clinical features with genetic factors enhances survival prediction for adults with acute myeloid leukemiaDouglas R A Silveira, Lynn Quek, Itamar S Santos, et al.
Blood|July 25, 2012
SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromesValeria Visconte, Heesun J Rogers, Jarnail Singh, et al.
Cell Death & Disease|February 24, 2018
Metformin exerts multitarget antileukemia activity in JAK2<sup>V617F</sup>-positive myeloproliferative neoplasmsJoão Agostinho Machado-Neto, Bruna Alves Fenerich, Renata Scopim-Ribeiro, et al.
British Journal of Haematology|October 17, 2024
External validation and calibration of the HoLISTIC Consortium's advanced-stage Hodgkin lymphoma international prognostic index (A-HIPI) in the Brazilian Hodgkin lymphoma registryValeria Buccheri, Frederico Rafael Moreira, Irene Biasoli, et al.
Investigational New Drugs|January 6, 2021
NT157, an IGF1R-IRS1/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemiaRenata Scopim-Ribeiro, João Agostinho Machado-Neto, Christopher A Eide, et al.
Hematology, Transfusion and Cell Therapy|June 10, 2022
Diagnosis and treatment of systemic mastocytosis in Brazil: Recommendations of a multidisciplinary expert panelElvira D Rodrigues Pereira Velloso, Geórgia A Padulla, Ana Maria Mósca de Cerqueira, et al.
Investigational New Drugs|November 27, 2021
STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cellsHugo Passos Vicari, Juan Luiz Coelho-Silva, Diego A Pereira-Martins, et al.
Pageof 11